Cover Image

Mechanisms underlying CD19-positive ALL relapse after anti-CD19 CAR T cell therapy and associated strategies

Abstract Chimeric antigen receptor (CAR) T cell therapy, especially anti-CD19 CAR T cell therapy, has shown remarkable anticancer activity in patients with relapsed/refractory acute lymphoblastic leukemia, demonstrating an inspiring complete remission rate. However, with extension of the follow-up p...

Full description

Saved in:

Bibliographic Details
Main Authors:	Yuru Nie (Author), Weiqing Lu (Author), Daiyu Chen (Author), Huilin Tu (Author), Zhenling Guo (Author), Xuan Zhou (Author), Meifang Li (Author), Sanfang Tu (Author), Yuhua Li (Author)
Format:	Book
Published:	BMC, 2020-05-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Successful treatment of acute B lymphoblastic leukemia relapse in the skin and testicle by anti-CD19 CAR-T with IL-6 knocking down: a case report
by: Ze-Fa Liu, et al.
Published: (2020)

Axicabtagene ciloleucel (KTE-C19), an anti-CD19 CAR T therapy for the treatment of relapsed/refractory aggressive B-cell non-Hodgkin’s lymphoma
by: Jain MD, et al.
Published: (2018)

Lower proportion of CD19+IL-10+ and CD19+CD24+CD27+ but not CD1d+CD5+CD19+CD24+CD27+ IL-10+ B cells in children with autoimmune thyroid diseases
by: Karolina Stożek, et al.
Published: (2020)

CD19+CD24hiCD38hi B Cell Dysfunction in Primary Biliary Cholangitis
by: Qubo Chen, et al.
Published: (2020)

Identification of Stem-Like Cells in Atrial Myxoma by Markers CD44, CD19, and CD45
by: Xianghe Song, et al.
Published: (2016)

Secondary donor-derived humanized CD19-modified CAR-T cells induce remission in relapsed/refractory mixed phenotype acute leukemia after allogeneic hematopoietic stem cell transplantation: a case report
by: Meng-Yun Li, et al.
Published: (2020)

Double-positive CD4 and CD8 Sézary syndrome
by: Denis Miyashiro, MD, et al.
Published: (2017)

Beyond CD19: Opportunities for future development of targeted immunotherapy in pediatric relapsed-refractory acute leukemia
by: Haneen eShalabi, et al.
Published: (2015)

The potential of CAR T therapy for relapsed or refractory pediatric and young adult B-cell ALL
by: Forsberg MH, et al.
Published: (2018)

Daratumumab and venetoclax in combination with chemotherapy provide sustained molecular remission in relapsed/refractory CD19, CD20, and CD22 negative acute B lymphoblastic leukemia with KMT2A-AFF1 transcript
by: Sophie Voruz, et al.
Published: (2021)

Haploidentical CD7 CAR T-cells induced remission in a patient with TP53 mutated relapsed and refractory early T-cell precursor lymphoblastic leukemia/lymphoma
by: Hai-ping Dai, et al.
Published: (2022)

Increased expression of CD20 and CD45 and diminished expression of CD19 are features of follicular lymphoma
by: Liu Q, et al.
Published: (2013)

First third-generation CAR T cell application targeting CD19 for the treatment of systemic IgM AL amyloidosis with underlying marginal zone lymphoma
by: Felix Korell, et al.
Published: (2023)

First‐in‐human study of JNJ‐63709178, a CD123/CD3 targeting antibody, in relapsed/refractory acute myeloid leukemia
by: Michael Boyiadzis, et al.
Published: (2023)

CD19+CD1dhiCD5hi B Cells Can Downregulate Malaria ITV Protection by IL-10 Secretion
by: Hongli Guan, et al.
Published: (2020)

Oil Red O positive vacuolated blasts in a case of CD45 negative, CD19 negative B-lymphoblastic leukemia
by: Diana O. Treaba, MD, et al.
Published: (2016)

Marked elevation of circulating CD19+CD38hiCD24hi transitional B cells give protection against neonatal sepsis
by: Sitao Li, et al.
Published: (2018)

Aberrant CD3 Expression in a Relapsed Plasma Cell Neoplasm
by: Jai-Hyang Go
Published: (2018)

CD19-immunoPET for noninvasive visualization of CD19 expression in B-cell lymphoma patients
by: Dominik Sonanini, et al.
Published: (2024)

Increased CD4+/CD8+ double-positive T cells in chronic Chagasic patients.
by: Nicolas A Giraldo, et al.
Published: (2011)

Pagetoid reticulosis positive for cytotoxic CD20 and CD30: A case report
by: Shufei Wei, et al.
Published: (2019)

Report on a Rare Case of Limited CD4/CD8 Double-Positive Paget Reticulosis with Literature Review
by: Zhang Y, et al.
Published: (2024)

First‐in‐human study of JNJ‐67571244, a CD33 × CD3 bispecific antibody, in relapsed/refractory acute myeloid leukemia and myelodysplastic syndrome
by: Rupa Narayan, et al.
Published: (2024)

Clinical significance of the CD98hc-CD147 complex in ovarian cancer: a bioinformatics analysis
by: Xin-Yue Zhou, et al.
Published: (2023)

Percentages of CD4+CD161+ and CD4−CD8−CD161+ T Cells in the Synovial Fluid Are Correlated with Disease Activity in Rheumatoid Arthritis
by: Jinlin Miao, et al.
Published: (2015)

Epigenetic regulation of CD133 and tumorigenicity of CD133 positive and negative endometrial cancer cells
by: Borger Darrell R, et al.
Published: (2010)

Expression of CD56 isoforms in primary and relapsed adult granulosa cell tumors of the ovary
by: Kämmerer Ulrike, et al.
Published: (2008)

Population pharmacokinetics and CD20 binding dynamics for mosunetuzumab in relapsed/refractory B‐cell non‐Hodgkin lymphoma
by: Brendan Bender, et al.
Published: (2024)

CD3+, CD56+, CD4−, CD8−, CD20−, CD30− Peripheral T-Cell Non-Hodgkin's Lymphoma: A Rare Case Report
by: Ashish Jagati, et al.
Published: (2017)

T-ALL with TEL/AML1 Translocation, Aberrant Expression of CD19 and 33: Case Report and Literature Review
by: Kave Jasseb, et al.
Published: (2016)

Circulating (CD3−CD19+CD20−IgD−CD27highCD38high) Plasmablasts: A Promising Cellular Biomarker for Immune Activity for Anti-PLA2R1 Related Membranous Nephropathy?
by: Agnieszka Pozdzik, et al.
Published: (2016)

Evaluation of Cell Biomarker Gene Expression (CD34) in ALL Patients and Healthy Controls Expression (CD34) in People with Leukemia
by: goolshan moradozadeh, et al.
Published: (2020)

CD4+ T cells expressing CD32 from HIV-1-positive patients are not enriched for proviral DNA
by: A.M. Spivak, et al.
Published: (2017)

Low relapse rates in TCR α/β and CD 19 depleted graft in haplo-identical stem cell transplantation for pediatric acute leukemia
by: Sonamani Ngangbam, et al.
Published: (2016)

Study on Drag Coefficient (CD) value of low-energy prototype class car / J. Jodiputra...[et al.]
by: J., Jodiputra, et al.
Published: (2020)

The effects of age and gender on CD3+ and CD19+ lymphocyte in gingival tissue and peripheral blood: an animal study
by: Turgut Demir, et al.
Published: (2016)

Diagnostic Challenges of CD4+/CD56+/CD123+ hematological neoplasms
by: Leandro S. Thiago, et al.
Published: (2013)

Expression of CD34, DOG1, S100 in CD117-negative and CD117-positive gastrointestinal stromal tumors with different potential of malignancy and clinical, morphological features
by: V. R. Skorik
Published: (2015)

Novel chimerized IgA CD20 antibodies: Improving neutrophil activation against CD20-positive malignancies
by: Mitchell Evers, et al.
Published: (2020)

Serum Levels of Soluble IL-2R, CD4 and CD8 in Chronic Active HCV Positive Hepatitis
by: C. Caruso, et al.
Published: (1994)